| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | UTS2R GPR65 OR9K2 GPER1 OPN3 FPR3 OR2W5P GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 OR14A16 BDKRB2 OR51F1 GNRHR2 PROKR2 ACKR3 OR6C76 OR6C75 OR4K1 OR52N4 CCR6 OR4F21 OR51G1 OR4F6 | 6.83e-09 | 884 | 169 | 27 | GO:0004930 |
| GeneOntologyMolecularFunction | somatostatin receptor activity | 2.46e-08 | 5 | 169 | 4 | GO:0004994 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB4 UTS2R GPR65 OR9K2 GPER1 OPN3 ROR1 FPR3 OR2W5P GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 OR14A16 BDKRB2 OR51F1 GNRHR2 PTK2B EDAR PROKR2 ACKR3 ABCC8 OR6C76 OR6C75 OR4K1 OR52N4 CCR6 OR4F21 OR51G1 OR4F6 | 1.02e-07 | 1353 | 169 | 32 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.78e-05 | 133 | 169 | 8 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.58e-05 | 140 | 169 | 8 | GO:0001653 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 8.46e-05 | 53 | 169 | 5 | GO:0008188 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.65e-05 | 28 | 169 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.63e-04 | 37 | 169 | 4 | GO:0042923 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.43e-04 | 18 | 169 | 3 | GO:0008569 | |
| GeneOntologyBiologicalProcess | somatostatin receptor signaling pathway | 6.14e-08 | 6 | 167 | 4 | GO:0038169 | |
| GeneOntologyBiologicalProcess | somatostatin signaling pathway | 6.14e-08 | 6 | 167 | 4 | GO:0038170 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | UTS2R GPR65 OR9K2 GPER1 OPN3 FPR3 OR2W5P GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 OR14A16 BDKRB2 OR51F1 GNRHR2 PTK2B CDK5R1 PROKR2 ACKR3 OR6C76 OR6C75 OR4K1 OR52N4 CCR6 OR4F21 OR51G1 PLCE1 OR4F6 | 7.92e-07 | 1395 | 167 | 30 | GO:0007186 |
| GeneOntologyBiologicalProcess | response to starvation | 1.81e-05 | 229 | 167 | 10 | GO:0042594 | |
| Domain | 7tm_1 | UTS2R GPR65 OR9K2 GPER1 OPN3 FPR3 OR2W5P GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 OR14A16 BDKRB2 GNRHR2 PROKR2 ACKR3 OR6C76 OR6C75 OR4K1 OR52N4 CCR6 OR4F21 OR51G1 OR4F6 | 2.00e-10 | 677 | 163 | 26 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | UTS2R GPR65 OR9K2 GPER1 OPN3 FPR3 OR2W5P GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 OR14A16 BDKRB2 GNRHR2 PROKR2 ACKR3 OR6C76 OR6C75 OR4K1 OR52N4 CCR6 OR4F21 OR51G1 OR4F6 | 2.57e-10 | 685 | 163 | 26 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | UTS2R GPR65 OR9K2 GPER1 OPN3 FPR3 OR2W5P GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 OR14A16 BDKRB2 GNRHR2 PROKR2 ACKR3 OR6C76 OR6C75 OR4K1 OR52N4 CCR6 OR4F21 OR51G1 OR4F6 | 3.10e-10 | 691 | 163 | 26 | PS50262 |
| Domain | GPCR_Rhodpsn | UTS2R GPR65 OR9K2 GPER1 OPN3 FPR3 OR2W5P GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 OR14A16 BDKRB2 GNRHR2 PROKR2 ACKR3 OR6C76 OR6C75 OR4K1 OR52N4 CCR6 OR4F21 OR51G1 OR4F6 | 3.20e-10 | 692 | 163 | 26 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | UTS2R GPR65 OR9K2 GPER1 OPN3 FPR3 OR2W5P GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 OR14A16 BDKRB2 PROKR2 ACKR3 OR6C76 OR6C75 OR4K1 OR52N4 CCR6 OR4F21 OR51G1 OR4F6 | 8.41e-10 | 670 | 163 | 25 | IPR017452 |
| Domain | Somatstn_rcpt | 2.78e-08 | 5 | 163 | 4 | IPR000586 | |
| Domain | Clathrin/coatomer_adapt-like_N | 7.08e-06 | 15 | 163 | 4 | IPR002553 | |
| Domain | Adaptin_N | 7.08e-06 | 15 | 163 | 4 | PF01602 | |
| Domain | ARM-type_fold | ZYG11A DNAJC13 DOCK8 BTAF1 NCDN AP2A1 AP2A2 XPO5 NOM1 EIF4G1 NCAPD2 PKP1 AP3D1 | 9.02e-06 | 339 | 163 | 13 | IPR016024 |
| Domain | - | 7.57e-05 | 2 | 163 | 2 | 2.60.40.1030 | |
| Domain | Clathrin_a-adaptin_app_Ig-like | 7.57e-05 | 2 | 163 | 2 | IPR013038 | |
| Domain | AP2_complex_asu | 7.57e-05 | 2 | 163 | 2 | IPR017104 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 7.57e-05 | 2 | 163 | 2 | IPR003164 | |
| Domain | Alpha_adaptin_C | 7.57e-05 | 2 | 163 | 2 | PF02296 | |
| Domain | ARM-like | ZYG11A DNAJC13 DOCK8 BTAF1 AP2A1 AP2A2 XPO5 NCAPD2 PKP1 AP3D1 | 1.34e-04 | 270 | 163 | 10 | IPR011989 |
| Domain | - | 1.48e-04 | 222 | 163 | 9 | 1.25.10.10 | |
| Domain | Dynein_heavy_dom-2 | 2.21e-04 | 14 | 163 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.21e-04 | 14 | 163 | 3 | PF08393 | |
| Domain | DHC_fam | 2.75e-04 | 15 | 163 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.75e-04 | 15 | 163 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.75e-04 | 15 | 163 | 3 | IPR004273 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 4.49e-04 | 4 | 163 | 2 | IPR015873 | |
| Domain | - | 4.49e-04 | 4 | 163 | 2 | 3.30.310.30 | |
| Domain | MA3 | 1.11e-03 | 6 | 163 | 2 | SM00544 | |
| Domain | MA3 | 1.11e-03 | 6 | 163 | 2 | PF02847 | |
| Domain | Initiation_fac_eIF4g_MI | 1.11e-03 | 6 | 163 | 2 | IPR003891 | |
| Domain | MI | 1.11e-03 | 6 | 163 | 2 | PS51366 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GPR65 GPER1 OPN3 FPR3 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 ACKR3 CCR6 | 5.95e-08 | 186 | 120 | 12 | MM15994 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | UTS2R GPR65 GPER1 OPN3 FPR3 GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 PROKR2 ACKR3 CCR6 | 1.30e-07 | 330 | 120 | 15 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | UTS2R GPR65 GPER1 OPN3 FPR3 GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 PROKR2 ACKR3 CCR6 | 1.46e-07 | 333 | 120 | 15 | MM14963 |
| Pathway | WP_GPCRS_NONODORANT | UTS2R GPR65 GPER1 OPN3 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 PROKR2 ACKR3 CCR6 | 4.17e-07 | 266 | 120 | 13 | MM15843 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | UTS2R GPER1 FPR3 SSTR1 SSTR2 SSTR3 SSTR5 BDKRB2 PROKR2 ACKR3 CCR6 | 9.25e-07 | 197 | 120 | 11 | M12289 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | UTS2R GPER1 FPR3 SSTR1 SSTR2 SSTR3 SSTR5 BDKRB2 PROKR2 ACKR3 CCR6 | 9.25e-07 | 197 | 120 | 11 | MM14970 |
| Pathway | WP_GPCRS_PEPTIDE | 2.09e-06 | 70 | 120 | 7 | MM15959 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GPR65 GPER1 OPN3 FPR3 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 ACKR3 CCR6 | 2.17e-06 | 260 | 120 | 12 | M39397 |
| Pathway | WP_PEPTIDE_GPCRS | 3.34e-06 | 75 | 120 | 7 | M39696 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | UTS2R GPR65 GPER1 OPN3 FPR3 GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 PROKR2 ACKR3 CCR6 | 3.65e-06 | 430 | 120 | 15 | MM15160 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | GPER1 OPN3 FPR3 GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 ACKR3 CCR6 | 6.44e-06 | 289 | 120 | 12 | MM15057 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | UTS2R GPR65 GPER1 OPN3 FPR3 GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 PROKR2 ACKR3 CCR6 | 8.91e-06 | 463 | 120 | 15 | M507 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | GPER1 OPN3 FPR3 GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 ACKR3 CCR6 | 1.49e-05 | 314 | 120 | 12 | M600 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | UTS2R GPR65 GPER1 OPN3 FPR3 OBSCN GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 PROKR2 PDE8B ACKR3 CCR6 | 3.24e-05 | 646 | 120 | 17 | MM14962 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | UTS2R GPR65 GPER1 OPN3 FPR3 OBSCN GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 PROKR2 PDE8B ACKR3 CCR6 | 9.09e-05 | 702 | 120 | 17 | M746 |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 1.25e-04 | 12 | 120 | 3 | MM15163 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 1.62e-04 | 13 | 120 | 3 | M27415 | |
| Pathway | WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION | 3.11e-04 | 16 | 120 | 3 | M48107 | |
| Pathway | WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM | 4.04e-04 | 113 | 120 | 6 | M48336 | |
| Pubmed | GPER1 OPN3 GPR55 SSTR1 SSTR2 SSTR3 SSTR5 CHRM4 BDKRB2 GNRHR2 ACKR3 CCR6 | 4.54e-10 | 200 | 174 | 12 | 18240029 | |
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 11897118 | ||
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 11753241 | ||
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 19330452 | ||
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 12414882 | ||
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 20717067 | ||
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 12021920 | ||
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 18936524 | ||
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 8449518 | ||
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 25962406 | ||
| Pubmed | Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors. | 3.01e-09 | 5 | 174 | 4 | 26474434 | |
| Pubmed | Somatostatin receptor subtypes in human type 2 diabetic islets. | 3.01e-09 | 5 | 174 | 4 | 20182388 | |
| Pubmed | Identification and characterization of a novel human cortistatin-like peptide. | 9.01e-09 | 6 | 174 | 4 | 9125122 | |
| Pubmed | 9.01e-09 | 6 | 174 | 4 | 1346068 | ||
| Pubmed | Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. | 9.01e-09 | 6 | 174 | 4 | 12145348 | |
| Pubmed | 9.01e-09 | 6 | 174 | 4 | 19423539 | ||
| Pubmed | 2.09e-08 | 7 | 174 | 4 | 22581439 | ||
| Pubmed | 2.09e-08 | 7 | 174 | 4 | 25149275 | ||
| Pubmed | Null mutant mouse models of somatostatin and cortistatin, and their receptors. | 2.09e-08 | 7 | 174 | 4 | 18206294 | |
| Pubmed | 2.64e-08 | 179 | 174 | 10 | 18577758 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 PALD1 NUP85 ESYT1 OBSCN LAMA5 BTAF1 MED13L ATP13A2 CHRM4 RYR1 MAP3K5 GRAMD2A CDK5R1 INTS5 PNPLA6 AP2A1 SBF2 EIF4G1 NCAPD2 AP3D1 DYNC1H1 | 4.02e-08 | 1105 | 174 | 22 | 35748872 |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 21503779 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 12474541 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 17609435 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 9892225 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 39197921 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 20739383 | ||
| Pubmed | 1.24e-07 | 10 | 174 | 4 | 16214911 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 19318729 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 25808161 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 33491286 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 10996426 | ||
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 11344221 | ||
| Pubmed | Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours. | 1.22e-06 | 5 | 174 | 3 | 9279525 | |
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 12759718 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPHB4 PTPMT1 NUP85 ESYT1 GCDH BTAF1 NCDN LARP4B INTS5 PNPLA6 AP2A1 XPO5 SEC24B EIF4G1 NCAPD2 OGA MTCH2 DYNC1H1 | 1.34e-06 | 942 | 174 | 18 | 31073040 |
| Pubmed | 1.75e-06 | 18 | 174 | 4 | 20810604 | ||
| Pubmed | DNAJC13 CARMIL2 NUP85 DOCK8 ESYT1 ANO10 NCDN CNOT6 LARP4B INTS5 PNPLA6 AP2A1 TUBGCP3 EIF4G1 NCAPD2 OGA MAP2K3 MTCH2 AP3D1 DYNC1H1 | 1.81e-06 | 1168 | 174 | 20 | 19946888 | |
| Pubmed | 2.18e-06 | 75 | 174 | 6 | 2834384 | ||
| Pubmed | Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. | 2.43e-06 | 6 | 174 | 3 | 9205124 | |
| Pubmed | 2.43e-06 | 6 | 174 | 3 | 22650988 | ||
| Pubmed | 2.43e-06 | 6 | 174 | 3 | 22419713 | ||
| Pubmed | 4.24e-06 | 7 | 174 | 3 | 16709866 | ||
| Pubmed | 8.30e-06 | 26 | 174 | 4 | 9226367 | ||
| Pubmed | 1.01e-05 | 9 | 174 | 3 | 11591131 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJC13 ATG13 GAS6 OBSCN BTAF1 WDR25 NCDN LRCH3 PTPDC1 PNPLA6 ACKR3 ABCC8 SBF2 VPS35L SPACA6 FNIP1 DHRSX MME MAP2K3 AFF4 DOP1A | 1.92e-05 | 1489 | 174 | 21 | 28611215 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ZNF618 MYO19 ROR1 OBSCN MAGEE2 RYR1 IVNS1ABP FBXL7 EDAR AGL KCNS2 NCR1 SNRNP200 DYNC1H1 | 2.22e-05 | 736 | 174 | 14 | 29676528 |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25008035 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 21912697 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 26531719 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 15118275 | ||
| Pubmed | Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes. | 2.49e-05 | 2 | 174 | 2 | 12376335 | |
| Pubmed | Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignancies. | 2.49e-05 | 2 | 174 | 2 | 24967740 | |
| Pubmed | Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly. | 2.49e-05 | 2 | 174 | 2 | 15914528 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 26661061 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 14602773 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17272399 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 14750962 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 24182563 | ||
| Pubmed | Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins). | 2.49e-05 | 2 | 174 | 2 | 2564002 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25925002 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 18624922 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25554089 | ||
| Pubmed | Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. | 2.49e-05 | 2 | 174 | 2 | 10713101 | |
| Pubmed | Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas. | 2.49e-05 | 2 | 174 | 2 | 22640914 | |
| Pubmed | SSTR1 and SSTR5 subtypes are the dominant forms of somatostatin receptor in neuroendocrine tumors. | 2.49e-05 | 2 | 174 | 2 | 20529830 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 15548214 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 19324858 | ||
| Pubmed | Expression of somatostatin receptors 1 and 2 in the adult mouse kidney. | 2.49e-05 | 2 | 174 | 2 | 15093692 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 19525223 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17652715 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25268135 | ||
| Pubmed | Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. | 2.49e-05 | 2 | 174 | 2 | 11527930 | |
| Pubmed | Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. | 2.49e-05 | 2 | 174 | 2 | 9177396 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17848636 | ||
| Pubmed | Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines. | 2.49e-05 | 2 | 174 | 2 | 7968260 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 9166719 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 22651821 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 15464758 | ||
| Pubmed | 6agonist selectivity determinants in somatostatin receptor subtypes I and II. | 2.49e-05 | 2 | 174 | 2 | 7929134 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 16954443 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 18653781 | ||
| Pubmed | Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia. | 2.49e-05 | 2 | 174 | 2 | 22311350 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 15857828 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 24634938 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 12035032 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25765179 | ||
| Pubmed | Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene. | 2.49e-05 | 2 | 174 | 2 | 12036598 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 33434183 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 31300420 | ||
| Pubmed | SPAG4L/SPAG4Lβ interacts with Nesprin2 to participate in the meiosis of spermatogenesis. | 2.49e-05 | 2 | 174 | 2 | 31144711 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17425570 | ||
| Pubmed | Somatostatin receptors SSTR2 and SSTR5 are expressed in the human thoracic duct. | 2.49e-05 | 2 | 174 | 2 | 21667819 | |
| Pubmed | The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5. | 2.49e-05 | 2 | 174 | 2 | 19748526 | |
| Pubmed | Somatostatin receptors type 2 and 5 expression and localization during human pituitary development. | 2.49e-05 | 2 | 174 | 2 | 24189142 | |
| Pubmed | NUP85 ESYT1 NCDN AP2A1 AP2A2 XPO5 NT5DC2 TUBGCP3 EIF4G1 NCAPD2 SNRNP200 DYNC1H1 | 2.78e-05 | 560 | 174 | 12 | 35241646 | |
| Pubmed | BICD2 PALD1 ATG13 MED13L NCDN XPO5 FNIP1 PPIP5K1 DYNC1H1 PLCE1 | 4.24e-05 | 407 | 174 | 10 | 12693553 | |
| Pubmed | 4.30e-05 | 14 | 174 | 3 | 29262337 | ||
| Pubmed | DNAJC13 ESYT1 LAMA5 DALRD3 LRCH3 INTS5 DNAH12 AP2A2 FNIP1 DHX29 AFF4 | 4.44e-05 | 496 | 174 | 11 | 31343991 | |
| Pubmed | OBSCN SOCS6 RYR1 MAP3K5 IVNS1ABP LARP4B AGL SYNE2 TUBGCP3 SMAD2 PLCE1 | 4.52e-05 | 497 | 174 | 11 | 23414517 | |
| Interaction | SST interactions | 4.91e-07 | 9 | 162 | 4 | int:SST | |
| Cytoband | 12q13.2 | 5.98e-05 | 55 | 175 | 4 | 12q13.2 | |
| GeneFamily | Somatostatin receptors | 8.88e-09 | 5 | 119 | 4 | 257 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-06 | 197 | 173 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.67e-06 | 170 | 173 | 7 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.85e-06 | 171 | 173 | 7 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 172 | 173 | 7 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.30e-06 | 182 | 173 | 7 | 9d727ab84da8de33f1021b492c90d8b4c2a8ea23 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.57e-06 | 183 | 173 | 7 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.57e-06 | 183 | 173 | 7 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.67e-06 | 190 | 173 | 7 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 1.00e-05 | 191 | 173 | 7 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-05 | 193 | 173 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Control-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 1.11e-05 | 194 | 173 | 7 | 7ab808dd1876b0eec2831caa16d04fd859b1dc50 | |
| ToppCell | Control-Myeloid-MoAM4|Control / Condition, Lineage and Cell class | 1.14e-05 | 195 | 173 | 7 | 211a736acbe875bd3c1942c62aaacc9b170ece6d | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.22e-05 | 197 | 173 | 7 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.26e-05 | 198 | 173 | 7 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.26e-05 | 198 | 173 | 7 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-05 | 199 | 173 | 7 | 5611b9e405a685a7a099d2f2d21dee3a939c2911 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.03e-05 | 85 | 173 | 5 | a7a5d82924cd4a41ab87b1abf13143635882a4b2 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.03e-05 | 85 | 173 | 5 | 86c5d71b66ff55c44d2d457865dda72e07e5ec53 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.03e-05 | 85 | 173 | 5 | 67336aa7ec02b64595ce7d5222d43cead92eb52e | |
| ToppCell | droplet-Liver-Npc-21m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 155 | 173 | 6 | d883a3869cf893d62741f26f641ed3923aba03f9 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.85e-05 | 160 | 173 | 6 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.85e-05 | 160 | 173 | 6 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.05e-05 | 168 | 173 | 6 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.05e-05 | 168 | 173 | 6 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 168 | 173 | 6 | b14fd50232887b6dca1f39014d43c6f66e5c3b5c | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.05e-05 | 168 | 173 | 6 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.22e-05 | 169 | 173 | 6 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.58e-05 | 171 | 173 | 6 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 172 | 173 | 6 | d061ea21bee179df5a525842e9a48621a8e1461b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 173 | 173 | 6 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-05 | 175 | 173 | 6 | bde785ff0c854646d7ab8571359e9d69a7bf013f | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.54e-05 | 176 | 173 | 6 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | facs-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | 7f58286fc8797e9bdcf8ece0849f55680905955d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 179 | 173 | 6 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 179 | 173 | 6 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.18e-05 | 179 | 173 | 6 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 7.41e-05 | 180 | 173 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.41e-05 | 180 | 173 | 6 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.41e-05 | 180 | 173 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, Lineage and Cell Type | 7.41e-05 | 180 | 173 | 6 | be665e801512f6aaf6b3ecb26153bbdeb24619ac | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 7.64e-05 | 181 | 173 | 6 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 181 | 173 | 6 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.87e-05 | 182 | 173 | 6 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.11e-05 | 183 | 173 | 6 | bd78e5c2670e67b4363078e3ca5a5b7081d24b7e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-05 | 183 | 173 | 6 | d1bf3abf42eb9d7facf775becf1338d1faadd647 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.36e-05 | 184 | 173 | 6 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.36e-05 | 184 | 173 | 6 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.36e-05 | 184 | 173 | 6 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.36e-05 | 184 | 173 | 6 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 8.36e-05 | 184 | 173 | 6 | 2817d530863e85dfdcd143b7a3dc5fc58a9cd98b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.61e-05 | 185 | 173 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.61e-05 | 185 | 173 | 6 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 8.61e-05 | 185 | 173 | 6 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.61e-05 | 185 | 173 | 6 | 8314dc608bc837df3037e89afd9db39737374ebc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-05 | 186 | 173 | 6 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 9.14e-05 | 187 | 173 | 6 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.14e-05 | 187 | 173 | 6 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 9.14e-05 | 187 | 173 | 6 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.41e-05 | 188 | 173 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.41e-05 | 188 | 173 | 6 | 624426815b789f0f35c327b8c3c0c05ba3aa7d98 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.68e-05 | 189 | 173 | 6 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.68e-05 | 189 | 173 | 6 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.68e-05 | 189 | 173 | 6 | 407d8a59969d83f014600aae1a55092283a13970 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 9.68e-05 | 189 | 173 | 6 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.68e-05 | 189 | 173 | 6 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.68e-05 | 189 | 173 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.97e-05 | 190 | 173 | 6 | 4cce4ddb79b7751d0103e10f71156977e0c34439 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 191 | 173 | 6 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 1.03e-04 | 191 | 173 | 6 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 1.03e-04 | 191 | 173 | 6 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 191 | 173 | 6 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 191 | 173 | 6 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 191 | 173 | 6 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.03e-04 | 191 | 173 | 6 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 192 | 173 | 6 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.06e-04 | 192 | 173 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 192 | 173 | 6 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 192 | 173 | 6 | faead5875a54fe8f1848ae36008aae4c0f7cb1c7 | |
| ToppCell | proximal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 192 | 173 | 6 | 86938c7d2bb1a7afb2b83828ca33dd137d366ec6 | |
| ToppCell | ASK452-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.06e-04 | 192 | 173 | 6 | f04ee5aaa54c39b7493098fb3d2f78168d6b8060 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 192 | 173 | 6 | e3be395a995dc8c0ebdae754057cfa59a270cae0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 193 | 173 | 6 | 30abf991ac17c18679ab7d633e7549c0ce841920 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 194 | 173 | 6 | 11ff53a748160570d2908ea9eb9779c038e5b676 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-04 | 194 | 173 | 6 | 74545942aded51a0f4ee96054b4ce12c4d99a8a0 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.12e-04 | 194 | 173 | 6 | f0707601883b234ed477c7704ca9a88efaefc3fd | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.12e-04 | 194 | 173 | 6 | 8bfd7c5be518b81b17913139bcb3ebea01f48dd5 | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 1.12e-04 | 194 | 173 | 6 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-04 | 194 | 173 | 6 | c25fc353001cdf9fcd772da5a254c857e555eab8 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.12e-04 | 194 | 173 | 6 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 122 | 173 | 5 | aca079f2f033cc1ac13c4ee02d490b6a514cbd5c | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 122 | 173 | 5 | ac38130010f76648757eac700a8039f3960ddde3 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 122 | 173 | 5 | 7ab0b63244116e74c5783c3293cf08224d094d0a | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.14e-04 | 122 | 173 | 5 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | Thalamus-Macroglia-CSF_related|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 122 | 173 | 5 | eb944243424460bf5c66aced3ed7b7a1b6486ac7 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 122 | 173 | 5 | 9b0d6b0a394560ff5aadcd3b21519c2393e6def8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 195 | 173 | 6 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass | 1.15e-04 | 195 | 173 | 6 | 569d1ebc5a5aa110a2430b096755ae35354040c4 | |
| ToppCell | Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-04 | 195 | 173 | 6 | 2af46e87947c16a7c2c367637e606cfbb8a78528 | |
| Drug | N-carbamylglutamate | 2.93e-08 | 13 | 173 | 5 | CID000121396 | |
| Drug | AC1O3HA7 | 4.77e-08 | 6 | 173 | 4 | CID006328526 | |
| Drug | Bim23268 | 1.11e-07 | 7 | 173 | 4 | CID005311026 | |
| Drug | Ee 581 | 2.20e-07 | 8 | 173 | 4 | CID003036100 | |
| Drug | BIM 23034 | 2.20e-07 | 8 | 173 | 4 | CID005492589 | |
| Drug | Somatostatin | 2.20e-07 | 8 | 173 | 4 | ctd:D013004 | |
| Drug | AC1Q5JP2 | 3.94e-07 | 9 | 173 | 4 | CID000134288 | |
| Drug | Tyr(3)-sms | 3.94e-07 | 9 | 173 | 4 | CID000123864 | |
| Drug | Depreotide | 3.94e-07 | 9 | 173 | 4 | CID009898619 | |
| Drug | Cyclo Ss-8 | 3.94e-07 | 9 | 173 | 4 | CID003081285 | |
| Drug | X Bb | 3.94e-07 | 9 | 173 | 4 | CID000445281 | |
| Drug | Hexapeptide 4 | 3.94e-07 | 9 | 173 | 4 | CID000194954 | |
| Drug | Octreotide | 4.31e-07 | 3 | 173 | 3 | DB00104 | |
| Drug | Seglitidum [latin] | 4.31e-07 | 3 | 173 | 3 | CID003035423 | |
| Drug | IBDU | 1.69e-06 | 27 | 173 | 5 | CID000022478 | |
| Drug | thsat | 1.72e-06 | 4 | 173 | 3 | CID000195015 | |
| Drug | Edotreotide | 2.18e-06 | 13 | 173 | 4 | CID000158782 | |
| Drug | SRA 880 | 3.04e-06 | 14 | 173 | 4 | CID005311376 | |
| Drug | L-817,818 | 4.12e-06 | 15 | 173 | 4 | CID005311375 | |
| Drug | L-796,778 | 5.46e-06 | 16 | 173 | 4 | CID005311373 | |
| Drug | ruthenium | 7.60e-06 | 94 | 173 | 7 | CID000023950 | |
| Drug | Cycam | 9.07e-06 | 18 | 173 | 4 | CID000122080 | |
| Drug | L-803,087 | 9.07e-06 | 18 | 173 | 4 | CID005311374 | |
| Drug | pasireotide | 9.07e-06 | 18 | 173 | 4 | ctd:C517782 | |
| Drug | Zwittergent 3-12 | 9.07e-06 | 18 | 173 | 4 | CID000084703 | |
| Drug | BIM-23027 | 1.48e-05 | 7 | 173 | 3 | CID005311025 | |
| Drug | N-N-C | 1.62e-05 | 42 | 173 | 5 | CID005278688 | |
| Drug | L-779,976 | 1.74e-05 | 21 | 173 | 4 | CID005311372 | |
| Drug | metaiodobenzylguanidine | 2.12e-05 | 22 | 173 | 4 | CID000060860 | |
| Drug | N1-aminopropylagmatine | 2.12e-05 | 22 | 173 | 4 | CID000541551 | |
| Drug | lanreotide | 2.35e-05 | 8 | 173 | 3 | ctd:C060347 | |
| Drug | ANB-NOS | 2.55e-05 | 23 | 173 | 4 | CID003080866 | |
| Drug | butamifos | 4.22e-05 | 26 | 173 | 4 | CID000037419 | |
| Drug | Rc 121 | 4.22e-05 | 26 | 173 | 4 | CID000127388 | |
| Drug | eniluracil | 4.93e-05 | 27 | 173 | 4 | CID000043157 | |
| Drug | lanreotide | 4.93e-05 | 27 | 173 | 4 | CID000071348 | |
| Drug | dtpa-sms | 5.72e-05 | 28 | 173 | 4 | CID000072128 | |
| Drug | cyclic d(ApAp | 5.74e-05 | 2 | 173 | 2 | CID000188955 | |
| Drug | AC-7954 | 5.74e-05 | 2 | 173 | 2 | CID009797568 | |
| Drug | 5-HIAA | 5.94e-05 | 129 | 173 | 7 | CID000001826 | |
| Drug | AC1L2HGV | 6.59e-05 | 29 | 173 | 4 | CID000072127 | |
| Drug | Tt 232 | 7.56e-05 | 30 | 173 | 4 | CID000164469 | |
| Drug | AN-201 | 8.63e-05 | 31 | 173 | 4 | CID000119196 | |
| Drug | 111In-pentetreotide | 8.63e-05 | 31 | 173 | 4 | CID003081912 | |
| Drug | AC1LA7UO | 9.80e-05 | 32 | 173 | 4 | CID000483172 | |
| Drug | CGS 8216 | 1.11e-04 | 33 | 173 | 4 | CID000104916 | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.23e-04 | 194 | 173 | 8 | 3570_DN | |
| Drug | vanadyl | DUSP2 SSTR2 SSTR3 MAP3K5 PTK2B PDE8B NCR1 MAP2K3 DYNC1H1 ALDH7A1 | 1.26e-04 | 307 | 173 | 10 | CID000061671 |
| Drug | amino acetate | 1.37e-04 | 65 | 173 | 5 | CID000177069 | |
| Drug | dimefox | 1.40e-04 | 35 | 173 | 4 | CID000008264 | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 1.41e-04 | 198 | 173 | 8 | 7168_DN | |
| Disease | Grand Mal Status Epilepticus | 9.08e-08 | 67 | 163 | 7 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 9.08e-08 | 67 | 163 | 7 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 9.08e-08 | 67 | 163 | 7 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 9.08e-08 | 67 | 163 | 7 | C0751523 | |
| Disease | Petit mal status | 9.08e-08 | 67 | 163 | 7 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 9.08e-08 | 67 | 163 | 7 | C0393734 | |
| Disease | Status Epilepticus | 1.01e-07 | 68 | 163 | 7 | C0038220 | |
| Disease | Neuroendocrine Tumors | 2.64e-05 | 11 | 163 | 3 | C0206754 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.81e-05 | 157 | 163 | 7 | DOID:14330 (implicated_via_orthology) | |
| Disease | retinal disease (implicated_via_orthology) | 4.48e-04 | 6 | 163 | 2 | DOID:5679 (implicated_via_orthology) | |
| Disease | waist-hip ratio | BICD2 NUP85 CYTL1 AQP1 ATP13A2 BDNF MEP1A PTPDC1 PDE8B ABCC8 SBF2 SYNE2 MAP2K3 AP3D1 SMAD2 KNL1 PLCE1 | 4.66e-04 | 1226 | 163 | 17 | EFO_0004343 |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 6.02e-04 | 30 | 163 | 3 | C1868672 | |
| Disease | total blood protein measurement | ZSWIM8 DNAJC13 ZNF618 CPS1 MAP3K5 CC2D2B SBF2 SLC25A10 PLCE1 | 9.19e-04 | 449 | 163 | 9 | EFO_0004536 |
| Disease | X-21467 measurement | 1.06e-03 | 9 | 163 | 2 | EFO_0020007 | |
| Disease | cortical surface area measurement | BICD2 PALD1 DNAJC13 ATG13 ROR1 MED13L CPS1 ATP13A2 ITIH5 CNOT6 FBXL7 ACKR3 NT5DC2 VPS35L SPAG17 MTCH2 PLCE1 | 1.29e-03 | 1345 | 163 | 17 | EFO_0010736 |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Combined immunodeficiency | 1.51e-03 | 41 | 163 | 3 | C0494261 | |
| Disease | microfibrillar-associated protein 2 measurement | 1.61e-03 | 11 | 163 | 2 | EFO_0801801 | |
| Disease | Charcot-Marie-Tooth disease | 1.62e-03 | 42 | 163 | 3 | cv:C0007959 | |
| Disease | epilepsy (implicated_via_orthology) | 2.16e-03 | 163 | 163 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | glutaroyl carnitine measurement | 2.27e-03 | 13 | 163 | 2 | EFO_0021005 | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.33e-03 | 100 | 163 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Seizures, Focal | 2.69e-03 | 104 | 163 | 4 | C0751495 | |
| Disease | Orofacial cleft | 2.84e-03 | 51 | 163 | 3 | HP_0000202 | |
| Disease | corpus callosum posterior volume measurement | 3.00e-03 | 52 | 163 | 3 | EFO_0010298 | |
| Disease | nervous system disorder | 3.17e-03 | 53 | 163 | 3 | C0027765 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 3.46e-03 | 16 | 163 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Multiple congenital anomalies | 3.91e-03 | 17 | 163 | 2 | C0000772 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 3.91e-03 | 17 | 163 | 2 | EFO_0800030 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 3.91e-03 | 17 | 163 | 2 | cv:C0270914 | |
| Disease | migraine disorder, systolic blood pressure | 4.38e-03 | 18 | 163 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | serum homoarginine measurement | 5.40e-03 | 20 | 163 | 2 | EFO_0005421 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MNLLIISFDRYFCVT | 121 | P08173 | |
| DLEQCYFSTRMSRIS | 366 | Q8NHY2 | |
| LVMRILYLDSSEICF | 591 | Q9BSJ8 | |
| LYSSICFLMLVSIDR | 141 | P30411 | |
| SCAYRINLAFMSTRQ | 186 | O75143 | |
| VVFLYMLCRDVISSE | 201 | Q15078 | |
| SQCRTTQSYVRALTM | 206 | P23560 | |
| LRAMFATRCDEYITQ | 746 | Q8TD16 | |
| YMRRSTCTINYSKDL | 516 | P49419 | |
| LRVDCTFSYLEVQAM | 61 | Q6F5E8 | |
| ACSASDQMRRYRTAF | 176 | P49640 | |
| RRTETMFNACLYFKS | 671 | C9J069 | |
| SCQISIFRALMYIIA | 86 | P29972 | |
| LTCISMDRYIAIVQA | 136 | P51684 | |
| RETNLRYLALESMCT | 341 | O95782 | |
| QMASTRLRLCTTLYQ | 466 | Q8IYW2 | |
| SVTRVLVALEMYSCN | 891 | Q8IYW2 | |
| NFRSSMYIEILISLC | 1446 | Q5JWR5 | |
| ARLVDYMICQSLISV | 521 | Q96M86 | |
| RIQYLNCSLDRVSMT | 1186 | Q9P1Z9 | |
| YQIRMESRACESTRL | 661 | Q7Z478 | |
| ASLCRQMTYSLTRFA | 66 | Q9UBX3 | |
| SLRSSYCSMLRNVDA | 641 | Q6DHV5 | |
| FNASIMTDLVRYTRQ | 1136 | Q9UHB7 | |
| ETNLRYLALESMCTL | 341 | O94973 | |
| VVERVDSCASMYSRS | 1096 | O14617 | |
| LRSMVQFIGRESKYC | 146 | Q9Y6C9 | |
| TSMTRLYYRDASACV | 71 | O14966 | |
| RVMELTYSNCRTTED | 61 | Q2M385 | |
| DLALMQTCYREAERS | 431 | Q86XR2 | |
| LTYRFQTCLTMQEVF | 596 | Q9ULE6 | |
| ECNDNTMRAFTYRTR | 91 | Q9NW15 | |
| YVDNMACRLARLLVT | 91 | Q8N1W1 | |
| SGQRLETEMQSYRCR | 1456 | Q5JPF3 | |
| ETEMQSYRCRLNAAL | 1461 | Q5JPF3 | |
| LYSVQMSTRLCTQLV | 156 | Q8NGE7 | |
| MAEIQSRLAYVSCVR | 1196 | Q8IY17 | |
| RLACTDTYRLQFMVT | 186 | O95013 | |
| FDILCITNSYTMILR | 211 | Q8NGI2 | |
| LSSQFMAYIEQRRIS | 401 | Q96II8 | |
| TFFRDLSAVYEMCRL | 1436 | Q71F56 | |
| NTRNLLTTDFVCMRF | 221 | Q8TD90 | |
| TFYCRLDTATSMFLL | 141 | O76036 | |
| AARRSMIDDTYQCLT | 146 | Q9UBB6 | |
| VYATLRFTMLECLSL | 86 | P54760 | |
| ISRYAFTTVSCRMLN | 61 | Q86UX2 | |
| LSRMDVTSCISYRNF | 126 | Q9Y6Y0 | |
| EYFRITASNRMYSLC | 1136 | Q86WG5 | |
| VTLETVLRCLQARYM | 46 | Q96H55 | |
| DACGMRFTRQYRLTE | 566 | Q14526 | |
| LVVSLMCSARAEYSN | 16 | Q9UNE0 | |
| AGFRMTRTVNTICYL | 51 | P25089 | |
| FCLSRENLASDMYLI | 166 | Q92615 | |
| SYSRLANELRVSCME | 41 | Q3SXM0 | |
| VMIVRRYSISSSVCS | 81 | A0A1B0GUA6 | |
| ISRSATICLAYLMQS | 261 | Q05923 | |
| QTYELMRCLEDLTSR | 596 | Q9BW27 | |
| VVMSHDRYVAVCRSL | 116 | A6NFC9 | |
| FEAREISLYSCIVQM | 96 | A6NGY5 | |
| VLLSMSIDRYVAVCN | 116 | Q8NGK1 | |
| VAMRRRCSQFVNYSK | 296 | Q8NGB9 | |
| HYSTIMNRRLCVIFV | 131 | Q8NGD4 | |
| RRFMENSSIIACYNE | 236 | O95263 | |
| IFMSACQDQTIRLYD | 186 | Q8TEB1 | |
| FYRRQKQLESAMRSC | 416 | Q9ULS6 | |
| ACTAYVDFMISVARL | 241 | P08473 | |
| IVMTYRLCSEQLSSQ | 1406 | Q6ZR08 | |
| ILYTCRQDDMEITRS | 931 | Q8NG31 | |
| VFTRECMSHYLRVFN | 651 | Q96CW5 | |
| SVQMFYVSTSRQLRR | 1136 | Q92887 | |
| IACYLVFATRMTADQ | 201 | A2A3K4 | |
| RCRSSSYTRQEFVDM | 1636 | O15230 | |
| TCYSRMRALSQEITR | 26 | Q9NRR1 | |
| ARKLYTIMNSFCRRD | 96 | Q9NRR1 | |
| MIISRYLLSVCGFRF | 651 | C9JG80 | |
| TICFISMDRFLAIRY | 111 | Q9Y2T6 | |
| TIMSDRICYQLIISS | 131 | A6NM76 | |
| MRSVSYVQRVALEFS | 1 | Q969R8 | |
| TSLRRMYIVNKEICS | 111 | Q13361 | |
| FCRDMTFDLRNRTYV | 71 | B3GLJ2 | |
| RDSRTDTVSYVFRNM | 5936 | Q5VST9 | |
| RSRSATMVAAYLIQV | 136 | Q8WUK0 | |
| LYSIRMLRCVEDLQT | 226 | Q9H1Y3 | |
| QFCLTYESAMTRLFL | 581 | Q8TCG5 | |
| AMTVCTLYAQSRLRR | 476 | Q9NQ11 | |
| TSMEYCIIEVNARLS | 706 | P31327 | |
| LFIRRLSCEQLGTYM | 96 | A1L1A6 | |
| RAVLSACSSYFRAMF | 81 | Q6TFL4 | |
| VTRSQACATLYLLMR | 1521 | Q8NF50 | |
| SVRFMATQCFATLIR | 1201 | O14981 | |
| LIRDTFRTYCQERLM | 66 | Q92947 | |
| QISIRYLDMTDCFVL | 271 | Q9UJT9 | |
| RRFDFMGTCVYVLAQ | 1266 | Q9Y6R7 | |
| SELVSFCYLHMREQR | 556 | Q5JV73 | |
| ALNEFRTTICNLYTM | 396 | Q8TF40 | |
| VTAFYRGCMTLEVNR | 636 | Q14393 | |
| VEFLYCDLASMTSIR | 96 | Q8N5I4 | |
| SIFFLTCMSVDRYLS | 131 | P25106 | |
| FTDTRYIIGMLERCT | 891 | O75165 | |
| SYCSQAMFRIRILEQ | 826 | Q8IY82 | |
| NTLVRALMTAVCYSA | 1476 | Q04637 | |
| FNYLCIMDSFSTRAR | 26 | Q96T53 | |
| RTMTRLCFLLFFSVA | 6 | Q8WWU7 | |
| DRCYLTMTQALEARL | 1886 | Q14204 | |
| IRRMCASYSELELVT | 156 | Q9H4A9 | |
| TFVMYNCARLATLFE | 401 | Q5D0E6 | |
| RFTELVCSLSDVYQM | 671 | Q14289 | |
| CFLVMSSSYLAFRIS | 321 | Q8IUY3 | |
| TSTRLDDRVYAMCQI | 1091 | O95487 | |
| FTTYSERLRICQMFV | 31 | W5XKT8 | |
| YCNSSTDRRVLLMFL | 56 | Q96E40 | |
| SACRSRRSMLSEYIV | 1721 | P21817 | |
| FSTTEMALALNRYLC | 2541 | P21817 | |
| DRTRPTALFSVMCYN | 181 | Q9ULM6 | |
| SSCIFMYIKTSARER | 251 | A6NL08 | |
| LDINMRTVDCFYTVT | 111 | P46734 | |
| LLLTVMSFDRYTAIC | 111 | Q8NHC5 | |
| RLACTDTYRLQFMVT | 186 | Q6IEY1 | |
| VRESFSMANNIILYC | 171 | Q99683 | |
| DILSSACYTVRNLMA | 656 | Q13835 | |
| RRYTISSALNLMQIC | 166 | P78346 | |
| SQSFLYRQVRRMTAV | 226 | Q8N0Z8 | |
| MCESYSRSLLRVSVA | 1 | Q5VWG9 | |
| RYLMGETQLCTTRCV | 51 | Q9BRU9 | |
| FYSEICNMLRATNRG | 696 | Q68CQ4 | |
| MFTSIYCLTVLSVDR | 141 | P30872 | |
| SFLLMTVVAYNICSR | 601 | Q96DN5 | |
| IFCLTVMSVDRYLAV | 131 | P32745 | |
| TCLMDRYQTLLRQLS | 2016 | Q8WXH0 | |
| TRLSNCANRTILYDM | 626 | O60502 | |
| YEVDRRMSDTFCTLS | 191 | Q9P212 | |
| VCRVMEYCSRELILS | 371 | Q14CZ7 | |
| YIALARAMRCSLFRT | 156 | Q99527 | |
| AMAICYSRIVLSVSR | 131 | Q96P88 | |
| SAIDLERLNRMYNCT | 246 | Q16819 | |
| SMSYCDESRLSNLLR | 136 | Q6P435 | |
| LRTFGRLCLYDMIQS | 26 | Q86WV5 | |
| RRNIFCTIMTSEDFL | 656 | Q5C9Z4 | |
| NTLSCIRVVYRRESM | 41 | Q6ZT89 | |
| TRTLMDIYVQCLSAL | 186 | Q6P9B9 | |
| SVFCLTVMSVDRYLA | 126 | P35346 | |
| SMYREVCSIRFLFTA | 156 | Q9NPE6 | |
| FCLTVMSIDRYLAVV | 131 | P30874 | |
| RQVKCMRVESSRYAT | 1486 | Q6Q759 | |
| MRVESSRYATVIANC | 1491 | Q6Q759 | |
| TDVRALQRYMCSRFF | 296 | Q96A09 | |
| AMRALTNYQRLCEAF | 256 | Q09428 | |
| YQDCTFFTRKEIMRL | 16 | Q96Q77 | |
| CYALIRLLESFETMA | 121 | Q15021 | |
| RCSTRITVYMVLNEC | 186 | Q9Y6N3 | |
| DMVIYFSALCLQISR | 361 | Q8WUD6 | |
| IACARFIGNRTVYME | 176 | Q01973 | |
| FLTVEQRMRACYYSL | 586 | P43403 | |
| TCRLASYEQRRMFSE | 131 | Q5HYL7 | |
| RSLYRDVMLETCRNL | 26 | Q15935 | |
| FVMSEIRTVYVTDCR | 606 | Q5T7W0 | |
| YERIFSMCVDSRSVL | 246 | Q7Z3J2 | |
| RNFSTDFYSLIMVCV | 406 | Q5GH72 | |
| GFEAVYQLTRMCTIR | 401 | Q15796 | |
| TSMRSIIFANYIARD | 21 | Q7L523 | |
| ANSDIFLYEILRSMC | 296 | P0CI26 | |
| TMSSRLIYTLRCGVF | 231 | Q9BSE2 | |
| RSSFTMLQRICTLYK | 191 | A6NDX5 | |
| YDLRSSSCLQQRERM | 2326 | Q9HCK1 | |
| LNRARMSFCVYSILG | 716 | Q9HAV4 | |
| STQAVCRGYLMRVEF | 791 | Q9UKX3 | |
| VVTMTLCYARISREL | 236 | Q8NFJ6 | |
| RLVRFSDLYMASLSC | 461 | Q9H857 | |
| MYRITVALTSLNCVA | 271 | Q8IYL9 | |
| RMLLQSSEGRCVYIT | 1366 | O75643 | |
| VLEVICSRMRYISSQ | 1466 | O75643 | |
| AYNVAVMFDRCRVTS | 171 | A7E2V4 | |
| LAQRTLYREVMLETC | 31 | Q7Z398 | |
| TCRSLRAVASMYVYV | 76 | Q9UKP6 | |
| RVLMYSFRTASRACT | 496 | Q64LD2 | |
| NSLLCSREMEVSYFA | 606 | Q6WRX3 | |
| VSRFMQVRSLQYLCR | 491 | O14544 | |
| MTQILERLCRFDYLT | 71 | Q6PFW1 | |
| MAVRFTTRSCIGRYN | 146 | Q6X784 | |
| CFSQLMLYAERAEAR | 31 | Q96IK0 | |
| YDTLMFCASRNTDRI | 731 | Q5FWF4 | |
| YRRFGCTVDMNIALT | 341 | P35573 | |
| SALVFFSCRTDMPYR | 336 | P17050 |